Bristol-Myers Squibb Co. (BMY) Dividend History

Bristol-Myers Squibb Co. is a global pharmaceutical company focused on discovering, developing, and delivering innovative medicines in areas such as oncology, immunology, cardiovascular, and neuroscience. Founded in 1858, it has a long history of advancing health through its diverse portfolio of prescription therapies.

Route 206 And Province Line Road, Princeton, NJ, 08543
Phone: (609) 252-4621
Website: https://www.bms.com
Dividend Yield: 5.20%
Dividend Frequency: Quarterly

Dividend History

Pay Date Amount Ex Dividend Date Record Date
August 01, 2025 $0.62 07/03/2025 07/03/2025
May 01, 2025 $0.62 04/04/2025 04/04/2025
February 03, 2025 $0.62 01/03/2025 01/03/2025
November 01, 2024 $0.60 10/04/2024 10/04/2024
August 01, 2024 $0.60 07/05/2024 07/05/2024
Show more

Dividends Summary

  • Bristol-Myers Squibb Co. has issued 87 dividend payments over the past 21 years
  • The most recent dividend was paid 65 days ago, on May 1, 2025
  • The first recorded dividend was paid on February 2, 2004
  • The highest dividend payout was $0.62 per share
  • The average dividend over this 21 year span is $0.39 per share
  • Bristol-Myers Squibb Co. has increased its dividend payments by 121.43% since 2004

Company News

  • The FDA has reduced monitoring requirements and removed REMS for Bristol Myers Squibb's CAR T cell therapies Breyanzi and Abecma, making these blood cancer treatments more accessible to patients.

    Benzinga
  • Two biotech companies, Editas Medicine and Sarepta Therapeutics, are experiencing severe challenges that make them unattractive investment options. Editas Medicine lacks marketable products and has a history of abandoned projects, while Sarepta Therapeutics is dealing with patient deaths related to its gene therapy treatment Elevidys.

    The Motley Fool
    Featured Companies: EDIT
  • The multiple sclerosis market is experiencing significant growth due to the rising prevalence of the disease, driving investment in research and development for effective treatments. The pipeline shows promise with over 60 active companies working on 75+ pipeline treatments, including promising drug candidates targeting novel mechanisms.

    GlobeNewswire Inc.
    Featured Companies: BIIB
  • Three stocks - Monster Beverage, Mondelez International, and Bristol-Myers Squibb - are positioned to weather the ongoing market volatility triggered by the U.S. trade war, offering resilience and growth potential.

    Investing.com
    Featured Companies: MDLZ MNST
Page data last updated 07/05/2025 03:12:55 UTC Dividend yield is calculated using only dividends that have already been paid. Future or declared dividends are not included